Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. PS Ratio 2021–2026
Current and historical P/S ratio for Gain Therapeutics Inc. (GANX): market cap divided by trailing twelve-month revenue. As of March 31, 2023 it is 282.28.
From: 03/31/2021To: 03/31/2023
Stock Price
TTM Revenue
PS Ratio
Gain Therapeutics Inc. PS Ratio — FAQ
Gain Therapeutics Inc. (GANX) ps ratio over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GANX's ps ratio history?
The chart and table above show Gain Therapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.